StressStudy 1
Lower stress scores and cortisol after 60 days
- What they did
- 64 adults with chronic stress; randomised, double-blind, placebo-controlled, 60 days.
- What they found
- Stress-scale scores fell significantly more than placebo on every scale used, and serum cortisol dropped significantly.
- Dose studied
- 600 mg/day (300 mg twice daily)
✓ Peer-reviewedRandomised controlled trial
Chandrasekhar et al., Indian Journal of Psychological Medicine, 2012
Read the study ↗
Stress hormonesStudy 2
Lower morning cortisol in stressed adults
- What they did
- 60 stressed but healthy adults; randomised, double-blind, 60 days.
- What they found
- Anxiety scores on the HAM-A (Hamilton Anxiety Rating Scale) fell more than placebo and morning cortisol dropped significantly. A second stress questionnaire, the DASS-21 (Depression Anxiety Stress Scales), did not reach significance.
- Dose studied
- 240 mg/day
✓ Peer-reviewedRandomised controlled trialLead author has had past funding from the extract maker
Lopresti et al., Medicine, 2019
Read the study ↗
Stress & anxietyStudy 3
Consistent reduction across 12 trials
- What they did
- Meta-analysis pooling 12 randomised trials with 1,002 adults.
- What they found
- Stress and anxiety scores fell versus placebo; the stress benefit was seen at 300–600 mg/day. The authors rate the certainty of evidence as low and call for higher-quality trials.
- Dose studied
- Various (clearest stress effect at 300–600 mg/day)
✓ Peer-reviewedMeta-analysis
Akhgarjand et al., Phytotherapy Research, 2022
Read the study ↗
SleepStudy 4
Fell asleep faster, slept more efficiently
- What they did
- 60 adults with insomnia and anxiety; randomised, double-blind, 10 weeks; sleep measured with wrist actigraphy and questionnaires.
- What they found
- Shorter time to fall asleep, and better sleep efficiency and sleep quality, than placebo.
- Dose studied
- 600 mg/day (300 mg twice daily)
✓ Peer-reviewedRandomised controlled trial
Langade et al., Cureus, 2019
Read the study ↗
SleepStudy 5
Small but significant improvement across 5 trials
- What they did
- Meta-analysis of 5 randomised trials with 400 adults.
- What they found
- A small, significant improvement in overall sleep, larger in people with insomnia, at 600 mg/day or more, and after 8 weeks or longer. Alertness on waking also improved.
- Dose studied
- Various
✓ Peer-reviewedMeta-analysis
Cheah et al., PLOS ONE, 2021
Read the study ↗
Memory & focusStudy 6
Better memory and attention scores
- What they did
- 50 adults with mild memory decline; randomised, double-blind, 8 weeks.
- What they found
- Immediate and general memory, attention and processing speed improved more than placebo.
- Dose studied
- 600 mg/day (300 mg twice daily)
✓ Peer-reviewedRandomised controlled trial (pilot)
Choudhary et al., Journal of Dietary Supplements, 2017
Read the study ↗
Strength & recoveryStudy 7
Greater strength gains with training
- What they did
- 57 young men starting resistance training; randomised, double-blind, 8 weeks.
- What they found
- Bigger gains in bench-press and leg-extension strength and in muscle size, a better recovery marker (creatine kinase), and a larger rise in testosterone than placebo.
- Dose studied
- 600 mg/day (300 mg twice daily)
✓ Peer-reviewedRandomised controlled trial
Wankhede et al., Journal of the International Society of Sports Nutrition, 2015
Read the study ↗
TestosteroneStudy 8
Higher testosterone in men over 40
- What they did
- 57 overweight men aged 40–70 with mild fatigue; randomised, double-blind, placebo-controlled crossover, 8 weeks per phase.
- What they found
- Testosterone rose 14.7% more than on placebo, and DHEA-S (another hormone) 18% more. Fatigue, vigour and sexual well-being improved in both groups, with no difference between them.
- Dose studied
- 600 mg/day
✓ Peer-reviewedRandomised controlled trial
Lopresti et al., American Journal of Men's Health, 2019
Read the study ↗
HormonesStudy 9
Testosterone up in men across 23 trials
- What they did
- Systematic review and meta-analysis of 23 randomised, placebo-controlled trials with 1,706 adults.
- What they found
- Testosterone rose in men (on average about 57 ng/dL more than placebo) but not in women, and cortisol fell. The authors note results varied between trials.
- Dose studied
- Various
✓ Peer-reviewedMeta-analysis
Fornalik et al., Planta Medica, 2026
Read the study ↗
MenopauseStudy 10
Fewer menopause symptoms in perimenopause
- What they did
- 100 women with menopause symptoms during perimenopause (the years leading up to menopause); randomised, double-blind, placebo-controlled, 8 weeks.
- What they found
- Menopause symptom scores fell significantly more than placebo across mood, physical and urogenital symptoms, and menopause-specific quality of life improved. Estradiol rose and FSH (follicle-stimulating hormone) and LH (luteinising hormone) fell; testosterone did not change.
- Dose studied
- 600 mg/day (300 mg twice daily)
✓ Peer-reviewedRandomised controlled trial
Gopal et al., Journal of Obstetrics and Gynaecology Research, 2021
Read the study ↗
Menopause & sleepStudy 11
Better sleep and fewer symptoms after menopause
- What they did
- 66 postmenopausal women aged 45–65; randomised, double-blind, placebo-controlled, 12 weeks.
- What they found
- Sleep quality on the PSQI (Pittsburgh Sleep Quality Index) improved far more than placebo (−5.2 vs −0.8 points), as did menopause symptom scores (−8.1 vs −1.2) and quality of life. Bone density did not change.
- Dose studied
- 600 mg/day
✓ Peer-reviewedRandomised controlled trial
Obhrai et al., Menopause, 2026
Read the study ↗